Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Update on dalbavancin activity tested against Gram-positive clinical isolates responsible for documented skin and skin-structure infections in US and European hospitals (2011–13): Table 1., Journal of Antimicrobial Chemotherapy, October 2015, Oxford University Press (OUP),
DOI: 10.1093/jac/dkv303.
You can read the full text:



The following have contributed to this page